Merit Medical Systems (NASDAQ:MMSI) Shares Break Below Fifty Day Moving Average – Should You Sell?

Posted by Brian Himes on Oct 31st, 2026

Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report) crossed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $88.60 and traded as low as $84.00. Merit Medical Systems shares last traded at $86.24, with a volume of 1,804,091 shares trading hands.

Key Headlines Impacting Merit Medical Systems

Here are the key news stories impacting Merit Medical Systems this week:

Positive Sentiment: Strong Q3 earnings beat expectations. Merit reported third-quarter revenue of $416.2 million, up 8.4% year over year and ahead of the $410.6 million consensus estimate. Non-GAAP EPS was $1.12 versus expectations of $1.04, while GAAP EPS rose 51% to $0.70. Merit Medical Q3 2026 results
Positive Sentiment: Profitability and cash generation improved. Organic constant-currency revenue increased 9%, GAAP operating margin expanded to 14.1% from 11.1%, and year-to-date operating cash flow reached $175.2 million, with $129.5 million in free cash flow.
Positive Sentiment: Full-year guidance was raised. Management increased its 2026 earnings outlook following the strong quarter, supporting expectations for continued growth. Merit Medical raises 2026 guidance
Positive Sentiment: Analysts raised targets. BTIG Research lifted its target from $105 to $110 and maintained a buy rating. Wells Fargo raised its target from $83 to $92, although it retained an equal-weight rating. Analysts raise Merit Medical price targets
Positive Sentiment: Cardiac-therapy capabilities expanded. Merit acquired Solo Pace, adding temporary pacing technology designed for patients with aortic stenosis and strengthening its TAVR-related product portfolio. Merit Medical acquires Solo Pace
Neutral Sentiment: Valuation remains a consideration. With the stock trading at roughly 36 times earnings and near its 52-week high, investors may be demanding continued execution, leaving limited room for disappointment.
Negative Sentiment: Some caution remains among analysts. Wells Fargo’s equal-weight rating and the company’s narrowed sales outlook temper the bullish impact of the earnings beat and guidance increase.

Analysts Set New Price Targets

MMSI has been the topic of several recent analyst reports. Piper Sandler boosted their price target on Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Zacks Research downgraded Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Monday, October 19th. Needham & Company LLC raised their target price on shares of Merit Medical Systems from $101.00 to $106.00 and gave the company a “buy” rating in a research note on Friday. JPMorgan Chase & Co. raised their target price on shares of Merit Medical Systems from $95.00 to $110.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Weiss Ratings upgraded shares of Merit Medical Systems from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, October 12th. Eight investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $105.55.

View Our Latest Report on MMSI

Merit Medical Systems Stock Performance

The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20. The stock’s fifty day moving average price is $88.60 and its 200-day moving average price is $77.14. The company has a market capitalization of $5.15 billion, a P/E ratio of 32.42, a PEG ratio of 2.33 and a beta of 0.51.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last issued its earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.08. Merit Medical Systems had a net margin of 9.94% and a return on equity of 14.37%. The business had revenue of $416.24 million during the quarter, compared to the consensus estimate of $410.56 million. During the same period last year, the business posted $0.92 EPS. Merit Medical Systems’s revenue was up 8.4% on a year-over-year basis. As a group, research analysts anticipate that Merit Medical Systems, Inc. will post 3.84 EPS for the current fiscal year.

Institutional Trading of Merit Medical Systems

Hedge funds have recently made changes to their positions in the business. Congress Asset Management Co. boosted its stake in shares of Merit Medical Systems by 6.4% during the 3rd quarter. Congress Asset Management Co. now owns 1,260,675 shares of the medical instruments supplier’s stock worth $108,708,000 after acquiring an additional 76,338 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Merit Medical Systems by 1.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier’s stock worth $85,287,000 after acquiring an additional 12,285 shares during the last quarter. William Blair Investment Management LLC bought a new stake in Merit Medical Systems in the 2nd quarter valued at $78,894,000. Maverick Capital Ltd. raised its stake in Merit Medical Systems by 46.9% in the 1st quarter. Maverick Capital Ltd. now owns 714,081 shares of the medical instruments supplier’s stock valued at $49,222,000 after acquiring an additional 227,915 shares during the period. Finally, Irenic Capital Management LP bought a new stake in Merit Medical Systems in the 2nd quarter valued at $37,623,000. 99.66% of the stock is owned by institutional investors and hedge funds.

Merit Medical Systems Company Profile

(Get Free Report)

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.